#asco2026

[bostongene]

BostonGene Highlights the Impact of AI in Cancer Research at ASCO 2026

BostonGene is showcasing new research at ASCO 2026 that demonstrates the clinical value of AI-powered models and comprehensive molecular profiling in oncology. The presented studies highlight innovative approaches to biomarker discovery, treatment response prediction, and patient stratification, helping advance precision medicine and improve outcomes across multiple cancer types.

Learn how AI-driven analytics and molecular insights are transforming the future of cancer care and clinical research.

[swanpapa]

GLP-1 수용체 작용제: 혁신적인 항암 치료의 가능성 GLP-1 수용체 작용제가 비만 치료제에서 항암제로 진화하고 있으며, 암 예방 및 전이 억제에 기여하는 연구 결과가 제시되고 있다. 생체 연구 및 임상 데이터에 따르면, GLP-1 약물이 종양 성장과 전이를 억제하는 데 효과적이라는 점이 입증되었고, 관련 시장의 빠른 변화가 나타나고 있다.... https://swanpapa.com/glp-1-%ec%88%98%ec%9a%a9%ec%b2%b4-%ec%9e%91%ec%9a%a9%ec%a0%9c-%ed%98%81%ec%8b%a0%ec%a0%81%ec%9d%b8-%ed%95%ad%ec%95%94-%ec%b9%98%eb%a3%8c%ec%9d%98-%ea%b0%80%eb%8a%a5%ec%84%b1/

[swanpapa]

Obesity Drugs: Revolutionizing Cancer Treatment and Prevention The Oncological Breakthrough of Obesity Medications: Mechanisms of Cancer Prevention, Metastasis Inhibition, and Structural Shifts in the Global Pharmaceutical Market…...